Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Windlas Biotech LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:543329NSE Symbol: WINDLASP/E(TTM):32.41
ISIN Demat:INE0H5O01029Div & Yield %:0.58EPS(TTM):30.76
Book Value(Rs):239.9966236Market Cap ( Cr.):2101.3Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 759.88630.96513.08465.93427.60328.85
Excise Duty0.000.000.000.000.000.00
Net Sales759.88630.96513.08465.93427.60328.85
Other Income 17.6513.479.976.713.090.96
Stock Adjustments 21.52-9.5915.274.74-3.6712.75
Total Income799.05634.84538.32477.38427.02342.56
EXPENDITURE :      
Raw Materials 493.38386.59340.71307.56270.74224.35
Power & Fuel Cost21.6116.1512.9011.0111.538.04
Employee Cost 122.9287.4670.3263.4158.3243.88
Other Manufacturing Expenses 11.5710.528.638.958.374.28
Selling and Administration Expenses 33.5335.9230.1323.0815.0915.68
Miscellaneous Expenses 4.286.635.413.7837.544.70
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure687.29543.27468.10417.78401.60300.93
Operating Profit111.7691.5770.2159.6025.4441.63
Interest 4.381.100.791.421.292.37
Gross Profit107.3890.4769.4258.1824.1539.26
Depreciation27.9913.4412.3612.1512.978.69
Profit Before Tax79.3977.0357.0646.0311.1830.57
Tax18.2717.3414.3510.134.848.24
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.471.540.06-2.661.33-0.13
Reported Net Profit60.6558.1442.6438.565.0122.46
Extraordinary Items 0.010.000.650.01-14.490.00
Adjusted Net Profit60.6458.1441.9938.5519.5022.46
Adjst. below Net Profit -0.54-0.24-0.16-0.18-26.370.00
P & L Balance brought forward226.29176.70141.84103.46124.8298.49
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 11.508.327.630.000.000.00
P & L Balance carried down274.90226.29176.70141.84103.46120.95
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %116.00110.0080.0070.000.000.00
Earnings Per Share-Unit Curr28.9427.9620.3817.697.8135.03
Earnings Per Share(Adj)-Unit Curr28.9427.9620.3817.69NANA
Book Value-Unit Curr241.31216.51192.42181.30310.39337.66